Reflections on the Pathogenesis of Abdominal Aortic Aneurysms

Dubost C. , Allary M. and Oeconoos N. Resection of an aneurysm of the abdominal aorta. Arch Surg, 1952, 64, 405–408.

Zarins C. K. and Harris E. J. Jr. Operative repair for aortic aneurysms: the gold standard. J Endovasc Surg., 1997, 4, 232–241.

Parodi J. C. , Palmaz J. C. and Barone H. D. Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg, 1991, 5, 491–499.

Biasi G. M. , Piglionica M. R. , Meregaglia D. European multicentre experience with modular device (Medtronic Aneurx) for the endoluminal repair of infrarenal abdominal aortic aneurysms. J Mal Vasc, 1998, 23, 374–380.

Zarins C. K. , White R. A. , Schwarten D. AneuRx stent graft versus open surgical repair of abdominal aortic aneurysms: nmulticenter prospective clinical trial. J Vasc Surg, 1999, 29, 292–305.

Cao P. , Zannetti S. , Parlani G. Epidural anesthesia reduces length of hospitalization after endoluminal abdominal aortic aneurysm repair. J Vasc Surg, 1999, 30, 651–657.

Nolthenius R. P. , Berg J. C. , Biasi G. M. Endoluminal repair of infrarenal abdominal aortic aneurysms using a modular stent-graft: one-year clinical results from a European multicentre trial. Cardiovasc Surg, 1999, 7, 503–507.

White G. H. , May J. , McGahan T. Historic control comparison of outcome for matched groups of patients undergoing endoluminal versus open repair of abdominal aortic aneurysms. J Vasc Surg, 1996, 23, 201–212.

Sternbergh W. C. 3rd and Money S. R. Hospital cost of endovascular versus open repair of abdominal aortic aneurysms: a multicenter study. J Vasc Surg, 2000, 31, 237–244.

Alcorn H. G. , Wolfson S. K. Jr. , Sutton-Tyrrell K. Risk factors for abdominal aortic aneurysms in older adults enrolled in The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol, 1996, 16, 963–970.

Grange J. J. , Davis V. and Baxter B. T. Pathogenesis of abdominal aortic aneurysm: update and look toward the future. Cardiovasc Surg, 1997, 5, 256–265.

Thompson R. W. Basic science of abdominal aortic aneurysms: emerging therapeutic strategies for an unresolved clinical problem. Curr Opin Cardiol, 1996, 11, 504–518.

Vorp D. A. , Trachtenberg J. D. and Webster M. W. Arterial hemodynamics and wall mechanics. Semin Vasc Surg, 1998, 11, 169–180.

Cronenwett J. L. , Murphy T. F. , Zelenock G. B. Actuarial analysis of variables associated with rupture of small abdominal aortic aneurysms. Surgery, 1985, 98, 472–482.

Campa J. S. , Greenhalgh R. M. and Powell J. T. Elastin degradation in abdominal aortic aneurysms. Atherosclerosis, 1987, 65, 13–21.

Powell J. T. Dilatation through loss of elastic. In The Cause and Management of Aneurysms, eds Greenhalgh R. M. , Mannick J. M. and Powell J. T. . WB Saunders, London 1990.

Tilson M. D. Histochemistry of aortic elastin in nonspecific abdominal aortic aneurysm disease. Arch Surg, 1988, 123, 503–505.

Baxter B. T. , McGee G. S. , Shively V. P. Elastin content, cross-links, and mRNA in normal and aneurysmal human aorta. J Vasc Surg, 1992, 16, 192–200.

Gargiulo M. , Stella A. , Sina M. Content and turnover of extracellular matrix protein in human “nonspecific” and inflammatory abdominal aortic aneurysms. Eur J Vasc Surg, 1993, 7, 546–553.

Cenacchi G. , Guiducci G. , Pasquinelli G. The morphology of elastin in non-specific and inflammatory abdominal aortic aneurysms: a comparative transmission, scanning and immunoelectronmicroscopy study. J Submicrosc Cytol Pathol, 1995, 27, 75–81.

Brophy C. M. , Reilly J. M. , Smith G. J. The role of inflammation in nonspecific abdominal aortic aneurysm disease. Ann Vasc Surg, 1991, 5, 229–233.

Reilly J. M. , Brophy C. M. and Tilson M. D. Characterization of an elastase from aneurysmal aorta which degrades intact aortic elastin. Ann Vasc Surg, 1992, 6, 499–502.

Vine N. and Powell J. Metalloproteinases in degenerative aortic disease. Clin Sci, 1991, 81, 233–239.

Herron G. S. , Uneori E. , Wong M. Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms. Artenoscler Thromb, 1991, 11, 1667–1677.

Newman K. M. , Ogata Y. , Malon A. M. Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm. Arterioscler Thromb, 1994, 14, 1315–1320.

Thompson R. W. , Holmes D. R. , Mertens R. A. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms: an elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invset, 1995, 96, 318–326.

Freestone T. , Turner R. J. , Coady A. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol, 1995, 15, 1145–1151.

McMillan W. D. , Patterson B. K. , Keen R. R. In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta. Arterioscler Thromb Vasc Biol, 1995, 15, 1139–1144.

McMillan W. D. , Patterson B. K. , Keen R. R. In situ localization and quantification of seventy-two-kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta. J Vasc Surg, 1995, 22, 295–305.

Thompson R. W. and Parks W. C. Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann NY Acad Sci, 1996, 800, 157–174.

Tamarina N. A. , McMillan W. D. , Shively V. P. Experssion of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Surgery, 1997, 122, 264–271.

Davis V. , Persidskaia R. , Baca-Regen L. Matrix metalloproteinases-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol, 1998, 18, 1625–1633.

Curci J. A. , Liao S. , Huffman M. D. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest, 1998, 102, 1900–1910.

McMillan W. D. , Tamarina N. A. , Cipollone M. Size matters: the relationship between MMP-9 expression and aortic diameter. Circulation, 1997, 96, 2228–2232.

McMillan W. D. and Pearce W. H. Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. J Vasc Surg, 1999, 29, 122–127.

Hovsepian D.M. , Ziporin S. , Sakurai M.K. Elevated plasma matrix metalloprotein-ase-9 (MMP-9): a potential marker of disease activity in patients with abdominal aortic aneurysms. J Vasc Interv Radiol. Submitted.

Pyo R. , Lee J.K. , Shipley J.M. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest. 2000, in press.

Ricci M. A. , Strindberg G. , Slaiby J. M. Anti-CD18 monoclonal antibody slows experimental aortic aneurysm expansion. J Vasc Surg, 1996, 23, 301–307.

Holmes D. R. , Petrinec D. , Wester W. Indomethacin prevents elastase-induced abdominal aortic aneurysms in the rat. J Surg Res, 1996, 63, 305–309.

Petrinec D. , Liao S. , Holmes D. R. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 93 kD gelatinase. J Vasc Surg, 1996, 23, 336–346.

Allaire E. , Forough R. , Clowes M. Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. J Clin Invst, 1998, 102, 1413–1420.

Curci J. A. , Petrinec D. , Liao S. X. Pharmacologic suppression of experimental abdominal aortic aneurysms: a comparison of doxycycline and four chemically modified tetracyclines. J Vasc Surg, 1998, 28, 1082–1093.

Bigatel D. A. , Elmore J. R. , Carey D. J. The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms. J Vasc Surg, 1999, 29, 130–138.

Moore G. , Liao S. , Curci J. A. Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908). J Vasc Surg, 1999, 29, 522–532.

Miralles M. , Wester W. , Sicard G. A. Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox2 isoform of cyclooxygenase. J Vasc Surg, 1999, 29, 884–893.

Curci J. A. , Mao D. , Bohner D. G. Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms. J Vasc Surg, 2000, 31, 325–342.

Thompson R. W. , Liao S. and Curci J. A. Therapeutic potential of tetracycline derivatives to suppress the growth of abdominal aortic aneurysms. Adv Dent Res, 1998, 12, 159–165.

Thompson R. W. and Baxter B. T. MMP inhibition in abdominal aortic aneurysms: rationale for a prospective randomized clinical trial. Ann NY Acad Sci, 1999, 878, 159–178.

Tilson M. D. , Elefriades J. and Brophy C. M. Tensile stength and collagen in abdominal aortic aneurysm disease. In The Cause and Management of Aneurysms, eds Greenhalgh R. M. , Mannick J. A. and Powell J. T. . WB Saunders, London 1990.

Satta J. , Juvonen T. , Haukipuro K. Increased turnover of collagen in abdominal aortic aneurysms, demonstrated by measuring the concentration of the aminoterminal propeptide of type III procollagen in peripheral and aortal blood samples. J Vasc Surg, 1995, 22, 155–160.

Satta J. , Haukipuro K. , Kairaluoma M. I. Aminoterminal propeptide of type III procollagen in the follow-up of patients with abdominal aortic aneurysms. J Vasc Surg, 1997, 25, 909–915.

Huffman M.D. , Curci J.A. , Moore G. Functional importance of connective tissue repair during the development of experimental abdominal aortic aneurysms. Surgery. 2000, in press.

Swanson R. J. , Littooy F. N. , Hunt T. K. Laparotomy as a precipitating factor in the rupture of intra-abdominal aneurysms. Arch Surg, 1980, 115, 299–304.

Dobrin P. B. , Baker W. H. and Gley W. C. Elastolytic and collagenolytic studies of artiers: implications for the mechanical properties of aneurysms. Arch Surg, 1984, 119, 405–409.

Dobrin P. B. and McKvicka R. Failure of elastin or collagen as possible critical connective tissue alterations underlying aneurysmal dilatation. Cardiovasc Surg, 1994, 2, 484–488.

Irizarry E. , Newman K. M. , Gandhi R. H. Demonstration of interstitial collagenase in abdominal aortic aneurysm disease. J Surg Res, 1993, 54, 571–574.

Mao D. , Lee J. K. , VanVickle S. J. Expession of collagenase-3 (MMP-13) in human abdominal aortic aneurysms and vascular smooth muscle cells in culture. Biochem Biophys Res Commun, 1999, 261, 904–910.

Lopez-Candales A. , Holmes D. R. , Liao S. Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol, 1997, 150, 993–1007.

Thompson R. W. , Liao S. and Curci J. A. Vascular smooth muscle cell apoptosis in abdominal aortic aneurysms. Coron Artery Dis, 1997, 8, 623–631.

Henderson E. L. , Gang Y. J. , Sukhova G. K. Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation, 1999, 99, 96–104.

Walton L. J. , Franklin I. J. , Bayston T. Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms. Circulation, 1999, 100, 48–54.

Liao S. , Curci J.A. , Kelley B. Accelerated replicative senescence of medial smooth muscle cells derived from abdominal aortic aneurysms as compared to the adjacent inferior mesenteric artery. J Surg. Res. 2000, in press.

Hak E. , Balm R. , Eikelboom B. C. Abdominal aortic aneurysm screening: an epidemiological point of view. Eur J Vasc Endovasc Surg, 1996, 11, 270–278.

Cheatle T. R. The case against a national screening programme for aortic aneurysms. Ann R Coll Surg Engl, 1997, 79, 90–95.

Mason J. M. , Wakeman A. P. , Drummond M. F. Population screening for abdominal aortic aneurysm: do the benefits outweigh the costs? J Public Health Med, 1993, 15, 154–160.

Katz D. A. , Littenberg B. and Cronenwett J. L. Management of small abdominal aortic aneurysms. Early surgery vs watchful waiting. JAMA, 1992, 268, 2678–2686.

Limet R. , Sakalihassan N. and Albrt A. Determination of the expansion rate and incidence of rupture of abdominal aortic aneurysms. J Vasc Surg, 1991, 14, 540–548.

Delin A. , Ohlsen H. and Swedenborg J. Growth rate of abdominal aortic aneurysms as measured by computed topography. Br J Surg, 1985, 72, 530–532.

Scott R. A. , Wilson N. M. , Ashton H. A. Influence of screening on the incidence of ruptured abdominal aortic aneurysms: 5-year results of a randomized controlled study. Br J Surg, 1995, 82, 1066–1070.

Tilson M. D. and Seashore M. R. Fifty families with abdominal aortic aneurysms in two or ore first-order relatives. Am J Surg, 1984, 147, 551–553.

Verloes A. , Sakalihasan N. , Limet R. Genetic aspects of abdominal aortic aneurysm. Ann NY Acad Sci, 1996, 800, 44–55.

Tromp G. , Wu Y. , Prockop D. J. Sequencing of cDNA from 50 unrelated patients reveals that mutations in the triplehelical domain of type III procollagen are an infrequent cause of aortic aneurysms. J Clin Invest, 1993, 91, 2439–2454.

Kuivaniemi H. , Watton S. J. , Price S. J. Candidate genes for abdominal aortic aneurysms. Ann NY Acad Sci, 1996, 800, 186–197.

McKusick V. The defect in Marfan syndrome. Nature, 1991, 352, 279–281.

Shores J. , Berger K. R. , Murphy E. A. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. N Engl J Med, 1994, 330, 1335–1341.

Niinammi H. , Aomi S. , Tagusari O. Extensive aortic reconstruction for aortic aneurysms in Marfan syndrome. Ann Thorac Surg, 1999, 67, 1864–1867.

Westaby S. Aortic dissection in Marfan's syndrome. Ann Thorac Surg, 1999, 67, 1861–1863.

Baumgartner W. A. , Cameron D. E. , Redmond J. M. Operative management of Marfarn syndrome: The Johns Hopkins experience. Ann Thorac Surg, 1999, 67, 1859–1860.

Ramirez F. and Pereira L. Mutations of extracellular matrix components in vascular disease. Ann Thorac Surg, 1999, 67, 1857–1858.

Pereira L. , Lee S. Y. , Gayraud B. Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc Natl Acad Sci USA, 1999, 96, 3819–3823.